2021-01-04,b'$RVNC $28.34 +0.10  +0.35%DAXI (RT002) - JUNIPER\nUpper limb spasticitY Phase 2 top-line data due 1Q 2021.\n$IMV $3.08 -0.06  -1.91%DPX-Survivac and  KEYTRUDA (pembrolizumab) - basket trial\nSolid tumors Phase 2 updated data due 1Q 2021.'
2021-01-01,"b""@imv IMV (owned lab's shares 6 YEARS RUNNING NOW). CEO, FRED ORS,filed with a share purchase: 15,000 shares New Year's Eve. [Acquired 15,450 Common Shares (Direct Ownership) $3.930 CAD through the public market on December 31st, 2020 (Holdings Change of plus-7.1%.) $imv"""
2021-01-01,b'BLOOD RED WEEK ENDS 2020.\n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $NVAX $ARCT $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/gqtLjzi4KM'
2021-01-01,b'26 of 27 COVID VACCINE STOCKS FALL! Bye 2020\n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $NVAX $ARCT $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $NK $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT https://t.co/jQQ6GOK1iV'
2020-12-31,b'$IMV considerable price movement -2.51 % change recently https://t.co/gUlC02K6tx'
2020-12-31,b'$IMV substantial stock price changes -4.20 % change recently https://t.co/SPcst5XWKv'
2020-12-30,b'Mild rebound. \n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $ARCT $NVAX $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $NK $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/nyP2wUfun5'
2020-12-30,"b'$IMV has successfully completed preclinical safety, GLP toxicology as well as immunogenicity and challenge studies confirming a favorable safety profile and potential for the long duration of antibody titers and protection against SARS-CoV-2. https://t.co/uj7PERY27E'"
2020-12-30,"b'$IMV \xe2\x80\x9cWe are encouraged by the data generated thus far. Results are consistent with the mechanism of action of our DPX delivery platform demonstrated across prior clinical studies with DPX-based vaccines and cancer immunotherapies,\xe2\x80\x9d https://t.co/uj7PERY27E'"
2020-12-30,"b'@Benswinningpics IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@TopGunTrader69 IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@Share_Talk @ZaksTradersCafe IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@eWhispers @Jumia_Group @pgtwindowsdoors @Chilis @CAE_Inc @Applied_Ind @arcosdorados @TufinTech @ReWalk_Robotics @Lemonade_Inc IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@adelaide_cap @OvationScience @imv_inc IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@adelaide_cap @IFTNA @Microbix IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@SurrogateCap IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@hemonctrader IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@crusadernz IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@madaznfootballr IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@R1Trader IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@SMgainz IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@crusadernz IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@DrReynoldsChi IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@TheStreet @mdbaccardax IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@TradetheMatrix1 IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@DilutionTracker IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'@AlertTrade IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews'"
2020-12-30,"b'IMV Reports Update on #COVID19  Vaccine Program\nRead More: https://t.co/950IIs6To3\n$IMV, a clinical-stage #biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases\n#Pharmacy #healthcare #data #PharmaNews\nPC: IMV Inc. https://t.co/BUKnm1egrm'"
2020-12-29,b'$ARCT collapses. \n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $NVAX $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $NK $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/SXMJOzG690'
2020-12-29,b'$IMV My valuations is at $3.66.  Waiting for it to come down. \n https://t.co/mqjcOXqtjA'
2020-12-29,b'$IMV Detailed Form 6 filed outlining where they are in #CovidVaccine development: https://t.co/DjeDkIEcGB'
2020-12-29,b'$IMV Preclinical studies and revised clinical plan to account for evolving regulatory landscape and emergence of new variants.'
2020-12-29,"b'$IMV Preclinical safety, long duration of antibody titers and potential for protection demonstrated in preclinical immunogenicity and challenge studies\n\nThe vaccine candidate is stable at 2\xc2\xb0C to 8\xc2\xb0C and room temperature for at least 3 months and ongoing'"
2020-12-29,b'$IMV keep an eye'
2020-12-29,b'A new filing Form 6-K  has been made at the SEC by  $IMV IMV Inc  https://t.co/ZfdLa6JS09'
2020-12-29,"b""Raymond James says IMV COVID plans look like 'red herring' to justify delay\n$IMV"""
2020-12-29,b'Breaking News: $IMV IMV Reports Update on COVID-19 Vaccine Program https://t.co/86IrAvPRZe\n    \n#HisDarkMaterials @gcassidy718 @starcevic_alex @simonstradeinc $AMRH $ACY $TWGL'
2020-12-29,b'$IMV might be worth taking a position when this bottoms  13.11 % change recently https://t.co/SPcst5XWKv'
2020-12-29,"b'RT @simonstradeinc: Tomrrow\xe2\x80\x99s #watchlist for #NYSE, #NASDAQ between $2 and $10: $ADAP $AHPI $AHT $ALPP $AMRH $AMRS $AQMS $ASX $AWX $AXL $BB\xe2\x80\xa6'"
2020-12-29,"b'Tomrrow\xe2\x80\x99s #watchlist for #NYSE, #NASDAQ between $2 and $10: $ADAP $AHPI $AHT $ALPP $AMRH $AMRS $AQMS $ASX $AWX $AXL $BBVA $BHR $BKD $BTU $CAN $CHU $CLNE $CREG $CYDY $DBI $DPW $EAF $EBON $ETM $EVFM $EVGN $FNB $FPAY $FTI $GCI $GEVO $GILT $GPRO $GSKY $HL $HT $HVBTF $IDEX $IMMR $IMV'"
2020-12-28,b'$IMV  Nice day here. \n\nWe put this on our FHT Weekly WL posted Sunday night. This morning the company released th... https://t.co/hRflONxuOi... https://t.co/hRflONxuOi'
2020-12-28,b'RT @IanGray44757496: Stop the Fogging Problem - what to do when your mask fogs your glasses https://t.co/tf99NlIkVQ via @YouTube \n\n$MRNA $A\xe2\x80\xa6'
2020-12-28,b'Stop the Fogging Problem - what to do when your mask fogs your glasses https://t.co/tf99NlIkVQ via @YouTube \n\n$MRNA $ARCT $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP #COVID #VACCINE #CORONAVIRUS $GOVX $GNBT #JNJ $BMY $GSK $WSJ'
2020-12-28,b'COVID VACCINE STOCK CARNAGE! $CVAC and $NK hit\n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $NVAX $ARCT $BNTX $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/W9Wb7Q1qEI'
2020-12-28,b'$IMV is pushing upwards!'
2020-12-28,b'RT @jerchess: $evfm $imv Propelling Konfusha to the top of the leaderboard in this week swing trade piks.  https://t.co/0Vhslaxo4j'
2020-12-28,"b'RT @CHItraders: $IMV vaccine candidate potentially effective against COVID-19, shares up 16%  | Seeking Alpha\nhttps://t.co/JgfDs4qELa'"
2020-12-28,b'Canadian SmallCap IMV Spikes 13% After Positive Results On #Covid19 Vaccine\n\n.@imv_inc $IMV $IMMVF announced the completion of pre-clinical safety as well as immunogenicity &amp; challenge studies with positive results\n\n$NVAX $ALT $VXRT #trading #StocksToWatch https://t.co/bLf3pB9rXH'
2020-12-28,b'$IMV - covid vaccine news/ developments. Add this one to your radar. Looks like it could have some potential to move higher from here based on chart alone.  Vaccine news just icing on the cake. @ACInvestorBlog @AlexDelarge6553 @Jyates5 @yatesinvesting @RadioSilentplay'
2020-12-28,b'$IMV trading up on all day on COVID vaccine news https://t.co/sbyqFOaiDV'
2020-12-28,b'$evfm $imv Propelling Konfusha to the top of the leaderboard in this week swing trade piks.  https://t.co/0Vhslaxo4j'
2020-12-28,b'IMV Reports Update on COVID-19 Vaccine Program | Business Wire $IMV \n\n#BIO #biotech #COVID19  https://t.co/tH6g4ULj8M'
2020-12-28,b'Rose Above 50 DMA today: $WEN $LNDC $CLPS $IMV $NDSN ... https://t.co/qwiJH6vr1O'
2020-12-28,b'Yes yes $IMV'
2020-12-28,b'$IMV pay me huge !'
2020-12-28,b'$IMV: posible throwback\xe2\x86\x97\xef\xb8\x8f -\n#IMV #IMVCCL TradingView https://t.co/ynuR0Sxpsn'
2020-12-28,b'$IMV not bad so far 3.50s ; 4 break could be breakout pt imo'
2020-12-28,"b'SOCIAL ACTIVITY: $IMV - IMV, Inc Common Shares https://t.co/Bi6ZbA1FsB \xf0\x9f\x93\x88 TradeIdeas via \xe2\x9f\xb6 https://t.co/ZgCyz4rX3x'"
2020-12-28,b'RT @thebubbleboard: Mon Dec 28\nIn the news this morning:\n\n$MYOV  $IDEX  $BFT  \n$IMV  $EVFM  $ABNB  \n$AAPL  $BRT  $AZN  \n\n#equitytrading #bu\xe2\x80\xa6'
2020-12-28,b'Mon Dec 28\nIn the news this morning:\n\n$MYOV  $IDEX  $BFT  \n$IMV  $EVFM  $ABNB  \n$AAPL  $BRT  $AZN  \n\n#equitytrading #bubbleboard #investing #business #stocktrading\n\nhttps://t.co/bBR7QNCn5W https://t.co/PeOEPqMZPY'
2020-12-28,"b'RT @Briefingcom: $IMV: IMV provides update on COVID-19 vaccine program; Preclinical safety, long duration of antibody titers and... https:/\xe2\x80\xa6'"
2020-12-28,"b'$IMV: IMV provides update on COVID-19 vaccine program; Preclinical safety, long duration of antibody titers and... https://t.co/puBn8l4t8p'"
2020-12-28,"b'$IMV +8.9% (provides update on COVID-19 vaccine program; Preclinical safety, long duration of antibody titers and potential for protection demonstrated in preclinical immunogenicity and challenge studies)'"
2020-12-28,b'IMV Spikes 13% Amid Positive Update On Covid-19 Vaccine Candidate https://t.co/tvwddMYTo2 $IMV #trading #markets #COVID\xe3\x83\xbc19'
2020-12-28,b'$IMV IMV Reports Update on COVID-19 Vaccine Program https://t.co/Vgnp0e707z'
2020-12-28,"b""It's make it happen Monday and here's what I may be trading IF we get an A+ Setup:  $AIRT $AQMS $BTWN $DPW $ENG $FLNT $FUSE $GEVO $GRNQ $IDEX $IMV $IPOC $JG $MAGS $MYOV $NPA $OCGN $OSMT $QELL $RMG $THBR #DayTrading https://t.co/oT9lSOrM1Y"""
2020-12-28,"b'#HealthCare Stocks Moving In #PreMarket Session, $OCGN shares rose 43.74% to $2.53. $OSMT shares rose 21.67% to $6.23. $MYOV stock rose 19.12% to $27.1. $BNGO shares rose 16.32% to $0.82. $JAGX stock rose by 16.08% to $0.83. $IMV shares rose by 11.14% to $3.39. #MarketUpdate https://t.co/7pJRs2qSFA'"
2020-12-28,"b'$IMV vaccine candidate potentially effective against COVID-19, shares up 16%  | Seeking Alpha\nhttps://t.co/JgfDs4qELa'"
2020-12-28,"b'Trump Signs $2.3 Trillion Relief Bill | Year-End Holiday Period: https://t.co/z9GYvManwF\n\n$AZN, $MYOV, $IMV, $BABA, $WB, $T, $DASH &amp; more...\n\n#News #Headlines #Stocks #StockMarket #Equities #Finance #Investing #Trading #DayTrading #NYSE #NASDAQ #WallStreet https://t.co/AMwYdFtWJN'"
2020-12-28,b'$IMV Reports Update on COVID-19 Vaccine Program | Business Wire\nhttps://t.co/nPLlLRmSk8'
2020-12-28,"b""RT @SMgainz: $IMV reports update on Covid-19 Vaccine program. IT'S JUST THE BEGINNING \xf0\x9f\x92\x89"""
2020-12-28,b'$IMV gapping up w update on their vaccine candidate for #COVID19 https://t.co/BwGPnliel9'
2020-12-28,"b""Benzinga Pro's Top 5 Stocks To Watch For Monday, Dec. 28, 2020: $IDEX, $CLH, $IMV, $ATIF, $OSMT\n#StocksToWatch #StockPicks #StockMarket\n\n@Benzinga @BenzingaPro https://t.co/5RdaLkkWLg"""
2020-12-28,b'Stocks Making The Biggest Moves PM: $BABA $T $AZN $DASH $WB $MYOV $PFE $TSLA $BA $IMV   &amp; More https://t.co/OsFxw8ZRlP'
2020-12-28,"b'$IMV (+8.9%) provides update on #COVID19 vaccine program; Preclinical safety, long duration of antibody titers and potential for protection demonstrated in preclinical immunogenicity and challenge studies'"
2020-12-28,"b""RT @MarketCurrents: $IMV - IMV's vaccine candidate potentially effective against COVID-19, shares up 16% https://t.co/XJy16x8N73"""
2020-12-28,"b'#Stocks making the biggest moves premarket: @AlibabaGroup, @ATT, @AstraZeneca, @DoorDash, others https://t.co/4txjVvdKTE $BABA $T $AZN $DASH $WB $MYOV $PFE $TSLA $BA $SVA $IMV'"
2020-12-28,b'$IMV (+8.9% pre) IMV Shares Surge After COVID Vaccine Program Update - TheStreet\n\nhttps://t.co/GClChMHNa0'
2020-12-28,"b""$IMV reports update on Covid-19 Vaccine program. IT'S JUST THE BEGINNING \xf0\x9f\x92\x89"""
2020-12-28,b'$IMV  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 51'
2020-12-28,"b""$IMV - IMV's vaccine candidate potentially effective against COVID-19, shares up 16% https://t.co/XJy16x8N73"""
2020-12-28,b'IMV Shares Surge After COVID Vaccine Program Update\nhttps://t.co/8pvEYlSWTA\n@mdbaccardax\n$IMV'
2020-12-28,b'IMV Shares Surge After COVID Vaccine Program Update\nhttps://t.co/QmSfjJJVTA\n@mdbaccardax\n$IMV'
2020-12-28,"b'$IMV, $IMV.CA Provides Update on Its COVID-19 Vaccine Program     #Coronavirus    #COVID19    #SARSCoV2       https://t.co/OyMg48yiIU'"
2020-12-28,b'RT @Trade_The_News: $IMV Reports update on COVID-19 vaccine program DPX-COVID-19; encouraged by the data generated thus far (IMV Inc)\n\n- Va\xe2\x80\xa6'
2020-12-28,b'$IMV Reports Positive Data for Covid-19 Vaccine Candidate'
2020-12-28,"b'$IMV in play! this could be $OCGN 2.0 \xf0\x9f\x98\x80\xf0\x9f\x98\x80\xf0\x9f\x9a\x80\xf0\x9f\xa4\x91 IMV Reports Successful Completion Of Preclinical Safety, Toxicology, Immunogenicity Studies Confirming Favorable Safety Profile, Potential For Long Duration Antibody Titers, Protection Against SARS-CoV-2'"
2020-12-28,"b'IMV Reports Successful Completion Of Preclinical Safety, Toxicology, Immunogenicity Studies Confirming Favorable Safety Profile, Potential For Long Duration Antibody Titers, Protection Against SARS-CoV-2\n\nRelated Tickers: $IMV $TSX\nRead more at: https://t.co/WKNsi8N7eH'"
2020-12-28,"b'$IMV(3.05) up 1  today reported update on the development of its vaccine candidate, DPX-COVID-19, for the prevention of COVID-19 infection caused by the novel coronavirus SARS-CoV-2.'"
2020-12-28,b'IMV Inc.  reports update on COVID-19 vaccine program\n$IMV'
2020-12-28,b'$PDSB Bio jumps out of BOTTOM TEN.\n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $NVAX $ARCT $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/541G1OvTX6'
2020-12-28,b'$IMV Reports update on COVID-19 vaccine program DPX-COVID-19; encouraged by the data generated thus far (IMV Inc)\n\n- Vaccine candidate is stable at 2\xc2\xb0C to 8\xc2\xb0C and room temperature for at least 3 months and ongoing\n(More at https://t.co/wpmVjg0tdO)'
2020-12-28,"b'$IMV Preclinical safety, long duration of antibody titers and potential for protection demonstrated in preclinical immunogenicity and challenge studies \n Vaccine candidate is stable at 2C to 8C and room temperature for at least 3 months and ongoing'"
2020-12-28,b'$IMV - IMV INC - VACCINE CANDIDATE IS STABLE AT 2\xc2\xb0C TO 8\xc2\xb0C AND ROOM TEMPERATURE FOR AT LEAST 3 MONTHS AND ONGOING'
2020-12-28,b'$IMV Reports Update on COVID-19 Vaccine Program'
2020-12-28,b'$IMV IMV Reports Update on COVID-19 Vaccine Program\nhttps://t.co/aR6KxBHBdc\n\n#vaccine #covid19'
2020-12-28,b'Four Horsemen Trading\nWeekly Watch-List for Dec 28\n#5\n\n$IMV- Swing Play/Covid Data\n\nFloat: 70M\nCash: 54\n\nSupport: 2.80 then 2.65\nResistance: 3.20 (20ema) then 3.45 (38% fib)\n\nCatalyst:\n- IMV Covid Vaccine Phase 1/2 Data - 1Q 2... https://t.co/ylRRJREctz https://t.co/e7b8iIawzl'
2020-12-27,b'$NK blows up! $NVAX way on top again.\n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $ARCT $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/2RxTTsFvrB'
2021-01-08,b'$IMV the valuation looks good  \xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd 3.72 % change recently https://t.co/mqjcOXqtjA'
2021-01-07,b'Breakout alert. Might really blast $IMV https://t.co/USJ3XpH0bh'
2021-01-07,"b'@thomcalandra @YouTube @Charlotte_McL @INN_Uranium @INN_Gold @INN_Resource Hey Thom thanks for your reply, i am really a small investor and with the couple tickers you have shared $NOU and $IMV my funds are topped, great video, thanks'"
2021-01-07,b'BLOWOUT UP DAY!! $ARCT on fire. GREEN INK FLOOD!\n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $NVAX $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/oIQtlVmBhX'
2021-01-07,b'Rose Above Upper Bollinger Band today: $LARK $EPAY $IMV $IRR $ADTX $JLS ... https://t.co/AyIukUGmib'
2021-01-07,b'Rose Above 50 DMA today: $IMV $PLM $BRP ... https://t.co/qwiJH6vr1O'
2021-01-06,b'Big Ones lead $MRNA $NVAX $BNTX up\n\nhttps://t.co/oqnENLGXM4\n\n$ARCT $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/C42TXEYllo'
2021-01-06,"b""$IMV exactly don't sell  -2.19 % change recently https://t.co/gUlC02K6tx"""
2021-01-06,b'IMV Inc. participates in a conference call hosted by BTIG\n$IMV'
2021-01-06,b'IMV Inc. management to meet virtually with BTIG\n$IMV'
2021-01-06,b'$IMV keep an eye on this one for a big breakout. Showing good signs. Update on #CovidVaccine sends it. https://t.co/kVUzwJfBy4'
